Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported) June 30, 2009

 

 

Oracle Corporation

(Exact name of Registrant as Specified in its Charter)

 

 

 

Delaware   000-51788   54-2185193

(State or Other Jurisdiction

of Incorporation)

   (Commission File Number)  

(IRS Employer

Identification No.)

 

500 Oracle Parkway, Redwood City, California   94065
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code (650) 506-7000

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨  

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨  

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨  

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨  

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 8.01 Other Events

Issuance of $4.50 Billion of Notes

On July 8, 2009, Oracle Corporation (“Oracle”) consummated the issuance and sale of $1,500,000,000 principal amount of its 3.750% Notes due 2014, $1,750,000,000 principal amount of its 5.000% Notes due 2019 and $1,250,000,000 principal amount of its 6.125% Notes due 2039 (collectively, the “Notes”), pursuant to an underwriting agreement dated June 30, 2009 among Oracle and Banc of America Securities LLC, Morgan Stanley & Co. Incorporated and Wachovia Capital Markets, LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

The Notes were offered pursuant to Oracle’s Registration Statement on Form S-3 filed on May 10, 2007 (Reg. No. 333-142796), including the prospectus contained therein (the “Registration Statement”), and a related preliminary prospectus supplement dated June 30, 2009 and a prospectus supplement dated June 30, 2009.

The material terms and conditions of the Notes are set forth in the Form of Officers’ Certificate filed herewith as Exhibit 4.08 and incorporated by reference herein and in the Indenture filed as Exhibit 10.34 to the Current Report on Form 8-K filed by Oracle Systems Corporation on January 20, 2006, and the First Supplemental Indenture filed as Exhibit 4.3 to the Registration Statement.

 

2

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

 

Exhibit No.

  

Description

4.08   Form of Officers’ Certificate setting forth the terms of the Notes
5.01   Opinion of Davis Polk & Wardwell LLP
23.02   Consent of Davis Polk & Wardwell LLP (contained in Exhibit 5.01)

 

3

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    ORACLE CORPORATION
Dated: July 8, 2009   By:  

/s/    Jeff Epstein

    Name:   Jeff Epstein
    Title:   Executive Vice President and Chief Financial Officer

 

4

EXHIBIT INDEX

 

Exhibit No.

  

Description

4.08   Form of Officers’ Certificate setting forth the terms of the Notes
5.01   Opinion of Davis Polk & Wardwell LLP
23.02   Consent of Davis Polk & Wardwell LLP (contained in Exhibit 5.01)

 

5